InnoCare Pharma Limited (9969:HK) PT Raised to HK$21 at Goldman Sachs

March 29, 2021 11:14 AM EDT
Get Alerts INCPF Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 16 | New: 68
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Goldman Sachs analyst Ziyi Chen raised the price target on InnoCare Pharma Limited (9969:HK) to HK$21.00 (from HK$18.50) while maintaining a Buy rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Intl Ratings

Related Entities

Goldman Sachs